Provider review
Aspire Health review
Sells the vial, states the dose, and lets a smaller dose stretch further.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
≈$105/mo all-in at 0.25 mg/wk
Visit Aspire HealthThe same vial is a ten-week supply at the lowest dose or a five-week supply at twice it, so the cost per milligram holds while the cost per month falls.
Price as published
Aspire Health
≈$105/mo all-in at 0.25 mg/wk
- Vs median
- $70/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Quotes off the lowest dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Nearly every telehealth provider sells a month, which means taking less out of the vial saves you nothing. Aspire sells the vial and says which dose it covers, so a deliberately small dose genuinely lasts longer for the same money — the structure this whole site exists to look for, and one of very few places it turns up. A separate monthly care fee is billed alongside the medication, so neither published number on its own is what leaves your account, and coverage is regional rather than national. Do the arithmetic before comparing it to anything: the per-vial figures cover between four and ten weeks depending on dose.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a cost that actually falls when your dose does, rather than a flat monthly plan
- You are inside the region it serves and can use a named clinical team rather than an anonymous network
- You want lab orders and interpretation inside the program rather than billed per event
Look elsewhere if
- You want one monthly number — nothing here is a monthly rate, and two of the figures cover different lengths of time
- You live outside its footprint, in which case none of these prices are available to you at all
- You want a named compounding pharmacy
What it actually costs
Price as published
≈$105/mo all-in at 0.25 mg/wk
- Vs median
- $70/mo below the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Quotes off the lowest dose
States plainly that its advertised figures are based on the lowest dosage and that higher doses may cost more. On a general ranking that is a warning; for someone staying small it is the one model that bills accordingly.
49 of the 548 programs here price a small dose this way. Sells medication by the vial with the dose it covers stated, so the same vial lasts ten weeks at the lowest dose and five weeks at twice that dose for the same money — the cost per milligram holds and the cost per month falls as the dose falls. A separate monthly care fee is billed alongside the medication, so the all-in figure is higher than the medication figure.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Included
- Labs
- Optional
- Pricing
- Check plan terms
What it does well
- Prices by the vial and states the dose each vial covers, so a smaller dose genuinely stretches further — the structure this whole site is looking for
- The same $129 vial covers ten weeks at 0.25 mg/week or five weeks at 0.5 mg/week, and the arithmetic checks: dose × weeks is constant within each band
- A named PA and NP clinical team rather than an anonymous prescriber network
- The new-patient consultation is free, with no enrollment charge
- Lab orders with interpretation and ongoing provider visits are covered by the monthly care fee rather than billed per event
- Offers a genuine brand-name path (Wegovy, Zepbound) alongside the compounded line
Pharmacy, labs and oversight
Aspire Health does not publicly identify the pharmacy that fills its prescriptions. Bloodwork is offered but not required. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What Aspire Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Aspire Health is a Nebraska-based telehealth practice that prescribes compounded semaglutide and tirzepatide formulated with B6, alongside brand-name Wegovy and Zepbound, through a named PA and NP clinical team. Its pricing is unusual for this category in that the medication is sold BY THE VIAL rather than by the month: the same 2.5 mg vial costs $129 whether it is dispensed as a ten-week supply at 0.25 mg weekly or a five-week supply at 0.5 mg weekly, so the cost per milligram is constant and the cost per month falls as the dose falls. A separate monthly medical-care fee covers lab orders with interpretation, provider visits and ongoing support, and is billed alongside the medication rather than inside it.
The honest cons
The advertised figures are PER-VIAL prices whose supply duration swings between four and ten weeks depending on the dose, so no number on the page is a monthly rate and two of them cannot be compared without doing the arithmetic yourself
- The monthly medical-care fee is billed separately from the medication, so neither published figure is what leaves your account
- Coverage is regional rather than national, so a reader outside its footprint cannot buy at these prices at all
- No compounding pharmacy is named
- The brand-name path is priced far above the compounded one, and the difference is not explained on the page where both appear
- Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Aspire Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs to compare with Aspire Health. Both are partners: we may earn a commission if you start care through these links.
Partner
Wellorithm
Compounded line not published · brand pens priced
No low-dose price published
Partner
MyDrHank
$259/mo sema · $349/mo tirz
Same price at every dose
Where this sits
#50 of 548
Ordered with the companies that pay us first, and Aspire Health is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What the evidence actually shows
- What microdosing GLP-1 costs
- Microdosing semaglutide
- Microdose & reconstitution calculator
- Vial waste calculator
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Another program to compare
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
- Vs median
- $26/mo below the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the Peter MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.